乙型肝炎表面抗原定量在抗病毒治疗中的意义
陈力元,王贵强
摘要(Abstract)：
<正>1在干扰素治疗中,乙型肝炎表面抗原(HBsAg)定量对疗效的预测价值1.1预测患者对干扰素治疗的应答①在干扰素治疗中,持续应答和最终转归的关系是非常密切的,干扰素治疗后出现持续应答的患者,其肝癌等肝病终末期事件的发生风险会大幅度降低;②在干扰素治疗过程中,疗效与治疗转归的关系非常明确,如何早期判断干扰素疗效,也被广泛关注。由于慢性
关键词(KeyWords)：
基金项目(Foundation):
作者(Author): 陈力元,王贵强
参考文献(References)：
- [1]Buster EH,Hansen BE,Lau GK,et al.Factors that predictresponse of patients with hepatitis B e antigen-positive chronichepatitis B to peginterferon-alfa[J].Gastroenterology,2009,137(6):2002-2009.
- [2]Chan HL,Wong VW,Tse AM,et al.Serum hepatitis B surfaceantigen quantitation can reflect hepatitis B virus in the liverand predict treatment response[J].Clin Gastroenterol Hepatol,2007,5(12):1462-1468.
- [3]Sonneveld MJ,Rijckborst V,Boucher CA,et al.Prediction ofsustained response to peginterferon alfa-2b for hepatitis B eantigen-positive chronic hepatitis B using on-treatment hepatitisB surface antigen decline[J].Hepatology,2010,52(4):1251-1257.
- [4]Piratvisuth T,Marcellin P.Further analysis is required toidentify an early stopping rule for peginterferon therapythat is valid for all hepatitis B e antigen-positive patients[J].Hepatology,2011,53(3):1054-1055.
- [5]Chan HL,Wong VW,Chim AM,et al.Serum HBsAgquantification to predict response to peginterferon therapy ofe antigen positive chronic hepatitis B[J].Aliment PharmacolTher,2010,32(11-12):1323-1331.
- [6]Chan HL,Wong GL,Chim AM,et al.Prediction of off-treatment response to lamivudine by serum hepatitis B surfaceantigen quantification in hepatitis B e antigen-negativepatients[J].Antivir Ther,2011,16(8):1249-1257.